Home › Funds › Palo Alto Investors LP › AGIO
Palo Alto Investors LP position in AGIO
AGIOS PHARMACEUTICALS INC · Health Care
Palo Alto Investors LP reported holding 200,984 shares of AGIO (AGIOS PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$6.7M, representing 0.99% of its reported portfolio and ranking #24 among its reported holdings. Palo Alto Investors LP has disclosed AGIO holdings in 7 of the last 7 reported quarters, going back to Q1 2025.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How Palo Alto Investors LP's AGIO position evolved
Palo Alto Investors LP first disclosed a stake in AGIO in Q1 2025 at 276,578 shares (US$8.1M). The position peaked in Q3 2025 at 265,497 shares, worth US$10.7M. Across 7 filings, Palo Alto Investors LP increased the stake 1 time(s), trimmed it 4 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 200,984 shares valued at US$6.7M — a reduction of -12,617 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2025 | 276.58K | $8.10M | New |
| Q2 2025 | 268.78K | $8.94M | Reduce |
| Q3 2025 | 265.50K | $10.66M | Reduce |
| Q4 2025 | 212.50K | $5.78M | Reduce |
| Q1 2026 | 213.60K | $7.23M | Add |
| Q2 2026 | 213.60K | $7.93M | Hold |
| Q3 2026 | 200.98K | $6.68M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About AGIO and 13F data
AGIO (AGIOS PHARMACEUTICALS INC) is a Health Care company. 27 other funds we track also report a position in AGIO — the largest reported positions include Farallon Capital Management (US$219.6M), FARALLON CAPITAL MANAGEMENT, L.L.C. (US$197.5M), ARMISTICE CAPITAL, LLC (US$85.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding AGIO
- Farallon Capital Management 5.92M sh · $219.59M · Q2 2026
- FARALLON CAPITAL MANAGEMENT, L.L.C. 5.94M sh · $197.49M · Q3 2026
- ARMISTICE CAPITAL, LLC 2.58M sh · $85.72M · Q3 2026
- Erste Asset Management GmbH 1.80M sh · $60.10M · Q3 2026
- ADAR1 Capital Management, LLC 1.14M sh · $37.89M · Q3 2026
- Foresite Capital Management VI LLC 827.13K sh · $27.50M · Q3 2026
More on Palo Alto Investors LP
FAQ
How long has Palo Alto Investors LP held AGIO?
Palo Alto Investors LP has disclosed AGIO holdings in 7 of the last 7 reported quarters, going back to Q1 2025.
What is Palo Alto Investors LP's current position in AGIO?
As of Q3 2026, Palo Alto Investors LP holds 200.98K shares of AGIO (AGIOS PHARMACEUTICALS INC), valued at $6.68M, representing 0.99% of its reported portfolio and ranking #24.
Has Palo Alto Investors LP been buying or selling AGIO?
In the latest 13F filing (Q3 2026), Palo Alto Investors LP reduced its position in AGIO. The position peaked in Q3 2025 at 265.50K shares.
Which other funds hold AGIO?
Other major institutional holders of AGIO include Farallon Capital Management, FARALLON CAPITAL MANAGEMENT, L.L.C., ARMISTICE CAPITAL, LLC, among 27 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.